Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

Multiplex - Business disruption again - learnings and better cash position to help - ICICI Securities

Posted On: 2021-04-20 11:05:26 (Time Zone: UTC)

PVR and INOX Leisure (INOX) stocks have corrected significantly on Covid second wave. We estimate >50% of screens are shut due to lockdown or low demand and the worst case scenario of 100% screen shutdown for a few weeks looks possible. However, faster-than expected vaccination (on new liberalised and accelerated phase 3 Covid vaccination), and decline in Covid cases would be hugely positive. Cost continues to remain the key lever in absence of revenues for multiplexes, which previously were curtailed by ~70%. Rent and CAM waivers / concessions are critical to restrict cash burn and the possibility remains that relief may come as in the first wave. PVR and INOX however have enough funding arrangements to sail through this situation. Unlike earlier, multiplexes are equipped with learnings from the previous shutdown and are better prepared this time, in our view. Industry consolidation remains the key theme on normalisation, and strong players such as PVR and INOX are expected to capitalise on the situation. Reiterate BUY on both PVR and INOX.

- Business disruption again on Covid second wave. Restrictions / curfews are returning in tandem with rise in Covid cases. The key states of Maharashtra, Delhi and Rajasthan have implemented curfew, thus shutting down cinema theatres mandatorily while multiplexes have voluntarily shut many screens on low demand. We understand key listed multiplexes are running at probably less than 50% of screens and the situation may only worsen as Covid continues to rise in other geographies. We don't rule out the worst situation of complete shutdown of all screens for a few weeks, even months. However, multiplexes are now equipped with learnings from the previous shutdown, hence they are prepared to handle the situation more prudently, in our view.

Government of India has announced a liberalized and accelerated phase 3 Covid vaccination from 1st May'21. In phase 3, everyone above 18 years' age are eligible to get Covid vaccine. We keep our faith on vaccination, as it may help in restricting Covid case, and open economy earlier than expected.

- Costs remain the key lever to restrict cash burn. In absence of no material revenues, companies will continue to control / optimise costs to restrict cash burn. In H1FY21, PVR had cut monthly expenses (excluding rent and CAM) to Rs283mn, down 67% YoY. Similarly, in Q2FY21, INOX cut its employee cost and other overheads (excluding power & fuel, rent and CAM) by 72% to Rs100mn/month. Multiplexes have also secured complete waivers on rents during the lockdown period and concessions till Mar'21 on low occupancies.

Rent and CAM are major costs for multiplexes. On normalised basis, PVR's rent + CAM cost (per quarter) is Rs1.5bn and that of INOX is Rs1bn. The evolving situation may warrant multiplexes to renegotiate again with mall owners for waivers or concessions as applicable. Any concession or waiver on rents would bring significant relief to multiplexes, and we assign a high probability on the concession front.

- Healthy balance sheet would help. At Q3FY21-end, PVR had gross borrowing of Rs15bn and cash of Rs3.7bn; it raised additional equity of Rs8bn in Feb'21. Even in the worst case scenario, where PVR is expected to pay entire rent + CAM, its cash will last more than three quarters. As at Jan'21-end (post fund raising of Rs2.5bn in Nov'20), INOX had gross debt of Rs1.15bn and cash of Rs1.4bn. It has taken Board approval to raise another Rs3bn in equity and, post fund raising, INOX too would have enough cash to sail through this challenging situation.

- New movie releases may be postponed. The Hindi segment did not see any major release of movie(s) even in Q4FY21 when the situation was improving. It is likely that producers / production houses were waiting for complete lifting of restrictions. However, South Indian language segments saw a few blockbuster releases such as Master. A few Hindi movies were expected to be released in April'21 (e.g. Sooryavanshi), but we think it will now be postponed. We now expect major releases only in H2FY22, hence the next two quarters may be washout for multiplexes. This may also force a few producers to evaluate selling their movie rights to OTT players as the latter continue to invest aggressively (this could affect near-term content supply for multiplexes, but it would be a transient impact).

- Industry consolidation may accelerate further. In our earlier report (refer), we highlighted Covid as a catalyst to accelerate consolidation in the India theatre chain business - and now the second wave will only put more pressure on weak players. Though large shutdowns are likely in the single-screen segment, it may drive multiplexes' occupancy higher. Our working shows 100bps higher occupancy boost EBITDA by 9.1% and 11.7% for PVR and INOX respectively, on normalisation. In FY20, single-screen cinema theatres' box office revenues were Rs65bn (53% of industry revenues), but they had higher admits at 620mn (66% of industry admits). They enjoyed higher occupancy at 36.5%, but lower ATP of Rs104.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Maintain BUY on Federal Bank - Pristine asset quality offsets a low provisioning buffer - HDFC Securities

YES SECURITIES on Colgate Palmolive 4QFY21 results - Growth still elusive but margins keep racing ahead

SELL recommendation on Vinati Organics - Robust quarter - HDFC Securities

Maintain ADD on Colgate Palmolive - Beat on all fronts; focus on new launches' success - HDFC Securities

Maintain BUY on Oberoi Realty - Blockbuster quarter - HDFC Securities

Just Dial - Q4FY21 Result Update - YES Securities

Colgate-Palmolive (India) Ltd - Q4FY21 Result Update - YES Securities

Gland Pharma - Q4FY21 Result Update - YES Securities

Oberoi Realty Ltd - Q4FY21 Result Update - YES Securities

Bharti Airtel - Q4 FY21 First cut: Inline - YES Securities

Colgate Palmolive (India) - More of the same - ICICI Securities

Federal Bank - Steady asset quality despite challenges - ICICI Securities

Rossari Biotech - Inorganic growth is key to watch - ICICI Securities

Garden Reach Shipbuilders & Engineers - Execution pickup expected in FY22E - ICICI Securities

Mindspace Business Parks REIT - Q4FY21 - Near-term weakness to persist - ICICI Securities

Oberoi Realty - New launches drive record sales bookings - ICICI Securities

Q4FY21 Company Update - Gokaldas Exports - ICICI Direct

Q4FY21 Result Update - Oberoi Realty - ICICI Direct

Q4FY21 Result Update - Federal Bank - ICICI Direct

Bharti Airtel - Q4FY21 First Cut - ICICI Direct

Maintain BUY on Cipla - Weak quarter, outlook promising - HDFC Securities

Maintain BUY on Larsen & Toubro - Growth returns - HDFC Securities

Escorts - Lowered demand guidance - HDFC Securities

Maintain ADD on Dr. Reddy's Labs - Sputnik V launch to lift near-term outlook - HDFC Securities

AU Small Finance Bank - Showcasing liability strength - cuts SA rate - ICICI Securities

Indigo Paints - The investments thesis is (nearly) intact - ICICI Securities

Greenpanel Industries - Strong growth momentum sustains - ICICI Securities

Aditya Birla Capital - Operating performance gathers momentum; company poised for RoE improvement - ICICI Securities

Dr. Reddy's Laboratories - Steady quarter; outlook intact - ICICI Securities

Cipla - Weak Q4; on track to sustain higher margins - ICICI Securities

Larsen & Toubro - Focus on margins and asset liquidation - ICICI Securities

Voltas - Q4FY21 Result Update - YES Securities

Mphasis - Q4FY21 Result Update - YES Securities

Dr Reddy's Laboratories - Q4FY21 Result Update - YES Securities

Sagar Cements Ltd - Q4FY21 Result Update - YES Securities

Greenpanel Industries Ltd - Q4FY21 Result Update - YES Securities

Larsen & Toubro Ltd - Q4FY21 Result Update - YES Securities

Balkrishna Industries - Growth momentum accelerates - ICICI Securities

Voltas - Healthy growth, uncertain outlook - ICICI Securities

Vedanta - Aluminium, Zinc India continue to drive earnings - ICICI Securities

Q4FY21 Result Update - SKF India - ICICI Direct

Q4FY21 Result Update - Sagar Cements - ICICI Direct

Q4FY21 Result Update - Dr Reddy's Laboratories - ICICI Direct

Q4FY21 Result Update - Dwarikesh Sugar - ICICI Direct

Q4FY21 Result Update - Indian Energy Exchange - ICICI Direct

Q4FY21 Result Update - Balkrishna Industries - ICICI Direct

Q4FY21 Result Update - Avadh Sugar & Energy - ICICI Direct

Q4FY21 Company Update - Vardhman Special Steel - ICICI Direct

Q4FY21 Result Update - Cipla Ltd - ICICI Direct

Q4FY21 Result Update - Larsen & Toubro - ICICI Direct

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020